FDA to launch drug marketing review

08/2/2005 | Wall Street Journal, The

The FDA is responding to criticism of drug manufacturers' direct-to-consumer advertising, a $4.1 billion industry in 2004, by launching a review of drug marketing. The review, which will examine issues such as the balance of drugs' risks and benefits in ads, the development and enforcement of guidelines, and the use of digital media, will begin with a public meeting to gather information and opinions.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Media

Job Title Company Location
Director, Operational Enablement and Excellence
Pandora Media, Inc.
Okaland, CA
Sales Director - ROBLOX (New York)
Programmatic Manager
A+E Networks
New York, NY
Assistant Professor or Instructor of Advertising
Loyola University Chicago
Chicago, IL
National Sales Manager/Midwest
American City Business Journals/The Business Journals